- Home
- Commercial Education
- Pharmaceutical & Medical Technology
- Global Expertise
- About Us
- Current Assignments
-
News & Blog
- Podcast 01 - What is the key to a successful partnership at a university?
- Podcast 02 - The future of UK Higher Education
- Podcast 03 - Building a successful education technology business
- Podcast 04 - How are education providers responding to increasing student expectations?
- Podcast 05 - Challenges and Opportunities for International School operator
- Podcast 06 - Doing it for Real
- Podcast 10 - The evolution of international education
- Podcast 10 - The changing dynamic of the return on investment for Higher Education students in the UK
- A view on the international schools market in the UAE.
- Podcast 07 - What are the challenges in building successful international clinical organisations?
- Podcast 08 - Education technology and a wider view on the academic publishing market
- Building successful eclinical businesses.
- Understanding the ELT market across ASEAN
- Decentralised/Hybrid/Virtual Trials - Hype or The New Norm?
- The Spencer Group: Our response to recruiting during the pandemic
- What is the key to leading a successful school in UAE through the pandemic?
- What implications will coronavirus have on Real World Evidence/data and the wider eclinical market?
- What implications will coronavirus have on higher education?
- Neil Rotherham: What is the impact of Covid-19 on the pharmaceutical technology market?
- What is impact of Covid-19 on school groups in China?
- What is the impact of Covid-19 on the international K-12 sector?
- What are the possible short, medium and long-term implications of Covid on the pharma sector?
- What have schools learnt when taking education online during Covid-19?
- What are the implications of Covid-19 on RBM and the wider pharmatech market?
- What are the implications of Covid-19 on the eCOA market?
- What are the possible implications of Covid-19 on the pharmaceutical technology sector?
- What are the possible implications of Covid-19 to Management Consultancy and to Higher Education?
- What are the possible implications of Covid-19 across the investment space in education?
- Dominic Farmer: A view on the possible implications of Covid-19 on the pharmatech sector.
- What are the possible implications of Covid-19 on the global education sector?
- What are the possible implications of Covid-19 on the biopharmaceutical and pharmatech markets?
-
News & Blog
- Podcast 01 - What is the key to a successful partnership at a university?
- Podcast 02 - The future of UK Higher Education
- Podcast 03 - Building a successful education technology business
- Podcast 04 - How are education providers responding to increasing student expectations?
- Podcast 05 - Challenges and Opportunities for International School operator
- Podcast 06 - Doing it for Real
- Podcast 10 - The evolution of international education
- Podcast 10 - The changing dynamic of the return on investment for Higher Education students in the UK
- A view on the international schools market in the UAE.
- Podcast 07 - What are the challenges in building successful international clinical organisations?
- Podcast 08 - Education technology and a wider view on the academic publishing market
- Building successful eclinical businesses.
- Understanding the ELT market across ASEAN
- Decentralised/Hybrid/Virtual Trials - Hype or The New Norm?
- The Spencer Group: Our response to recruiting during the pandemic
- What is the key to leading a successful school in UAE through the pandemic?
- What implications will coronavirus have on Real World Evidence/data and the wider eclinical market?
- What implications will coronavirus have on higher education?
- Neil Rotherham: What is the impact of Covid-19 on the pharmaceutical technology market?
- What is impact of Covid-19 on school groups in China?
- What is the impact of Covid-19 on the international K-12 sector?
- What are the possible short, medium and long-term implications of Covid on the pharma sector?
- What have schools learnt when taking education online during Covid-19?
- What are the implications of Covid-19 on RBM and the wider pharmatech market?
- What are the implications of Covid-19 on the eCOA market?
- What are the possible implications of Covid-19 on the pharmaceutical technology sector?
- What are the possible implications of Covid-19 to Management Consultancy and to Higher Education?
- What are the possible implications of Covid-19 across the investment space in education?
- Dominic Farmer: A view on the possible implications of Covid-19 on the pharmatech sector.
- What are the possible implications of Covid-19 on the global education sector?
- What are the possible implications of Covid-19 on the biopharmaceutical and pharmatech markets?
22 Apr 2020
What are the possible short, medium and long-term implications of Covid on the pharma sector?
Mark Maietta has a career spanning across 20 years including leadership roles in organisations such as Pfizer, CRF and Clariness. He is currently the President and Chief Commercial Officer at YPrime, a major player in eCOA, IRT, clinical data science and analytics. In this podcast, Mark discusses his view on the possible short, medium and long term implications of Covid on the pharmaceutical sector.
Listen to the Podcast below:
Services
Services
The Spencer Group
9 Greyfriars Road,
Reading,
Berkshire,
RG1 1NU
t: +44 (0)118 935 9444
e: info@spencergroup.com
Copyright © Spencer Group 2020
Website by Supreme